Community oncologists cited prior authorization as a care barrier, even as AI adoption doubled in 2026, according to the Oncology Care Index.
|Articles|February 8, 2019
COA Releases 2018 Year in Review
The Community Oncology Alliance has released its 2018 Year in Review, offering a comprehensive look at highlights and successes from the year.
Advertisement
The Community Oncology Alliance has released its 2018 Year in Review, offering a comprehensive look at highlights and successes from the year. The Year in Review includes action taken on key legislation and public policy, leaders and conveners for community oncology, support for community oncology practices and professionals, and more. Highlights include actions taken against proposed cuts to reimbursement, negative effects of pharmacy benefit managers, and cancer clinic consolidation.
Read the
Advertisement
Related to this article
Advertisement
Advertisement
Trending on AJMC
1
Peptide Regulation Debate Intensifies After FDA Advisory Panel's Controversial Vote
2
Opposing Sides of 340B Debate Converge on Data Clearinghouse, Patient Definition
3
Health System Pharmacies Keep Patients on GLP-1 Therapy
4
Community Oncologists Ready to Innovate, but Barriers Remain
5